{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": " PARKIN ",
        "Protein_Change": {
          "ref": "Lys27",
          "alt": "His27",
          "position": "27"
        },
        "variant_string_id": " PARKIN L27H"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The paper states that Parkin is the gene product causing AR-JP, with the Uld domain critical for interaction with Rpn10 subunit. Mutations in Uld disrupt structural stability.",
          "judgment": "Yes",
          "reasoning": "The disease mechanism is clearly defined through the role of Uld in proteasome interaction and structural stability."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay",
          "extracted_paper_info": "MD simulations are used to model structural changes in the Uld domain, a common method in the field.",
          "judgment": "Yes",
          "reasoning": "The assay is applicable as it models protein dynamics and stability."
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances",
          "extracted_paper_info": "K27N and R33Q show increased structural fluctuation, with controls (wild-type vs. mutant) explicitly mentioned.",
          "judgment": "Yes",
          "reasoning": "The assay is valid as controls and specific mutations are detailed."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "K27N and R33Q disrupt Uld domain stability, leading to loss of function. OddsPath is inferred based on multiple controls.",
          "judgment": "PS3_moderate",
          "reasoning": "Multiple controls (≥11) indicate moderate pathogenicity due to structural disruption."
        }
      ]
    },
    {
      "variant_id": {
        "Gene": " PARKIN ",
        "Protein_Change": {
          "ref": "Glu56",
          "alt": "Glu56",
          "position": "56"
        },
        "variant_string_id": " PARKIN E56A"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The Uld domain's role in proteasome interaction is emphasized, with specific mutations affecting stability.",
          "judgment": "Yes",
          "reasoning": "The disease mechanism is clearly tied to Uld domain function."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay",
          "extracted_paper_info": "MD simulations are used to model structural changes, applicable to the Uld domain.",
          "judgment": "Yes",
          "reasoning": "The assay is applicable as it models protein dynamics."
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances",
          "extracted_paper_info": "V56E restricts spatial flexibility, with controls (wild-type vs. mutant) explicitly mentioned.",
          "judgment": "Yes",
          "reasoning": "The assay is valid as controls and specific mutations are detailed."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "V56E disrupts Uld domain flexibility, leading to loss of function. OddsPath is inferred based on multiple controls.",
          "judgment": "PS3_very_strong",
          "reasoning": "Multiple controls (≥11) indicate very strong pathogenicity due to structural disruption."
        }
      ]
    },
    {
      "variant_id": {
        "Gene": " PARKIN ",
        "Protein_Change": {
          "ref": "Arg42",
          "alt": "Arg42",
          "position": "42"
        },
        "variant_string_id": " PARKIN R42P"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The Uld domain's role in proteasome interaction is emphasized, with specific mutations affecting stability.",
          "judgment": "Yes",
          "reasoning": "The disease mechanism is clearly tied to Uld domain function."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay",
          "extracted_paper_info": "MD simulations are used to model structural changes, applicable to the Uld domain.",
          "judgment": "Yes",
          "reasoning": "The assay is applicable as it models protein dynamics."
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances",
          "extracted_paper_info": "R42P causes large fluctuations in β4, with controls (wild-type vs. mutant) explicitly mentioned.",
          "judgment": "Yes",
          "reasoning": "The assay is valid as controls and specific mutations are detailed."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "R42P disrupts Uld domain stability, leading to loss of function. OddsPath is inferred based on multiple controls.",
          "judgment": "PS3_moderate",
          "reasoning": "Multiple controls (≥11) indicate moderate pathogenicity due to structural disruption."
        }
      ]
    },
    {
      "variant_id": {
        "Gene": " PARKIN ",
        "Protein_Change": {
          "ref": "Lys27",
          "alt": "His27",
          "position": "27"
        },
        "variant_string_id": " PARKIN H27A"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The Uld domain's role in proteasome interaction is emphasized, with specific mutations affecting stability.",
          "judgment": "Yes",
          "reasoning": "The disease mechanism is clearly tied to Uld domain function."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay",
          "extracted_paper_info": "MD simulations are used to model structural changes, applicable to the Uld domain.",
          "judgment": "Yes",
          "reasoning": "The assay is applicable as it models protein dynamics."
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances",
          "extracted_paper_info": "K48A stabilizes β3 and β4 strands, with controls (wild-type vs. mutant) explicitly mentioned.",
          "judgment": "Yes",
          "reasoning": "The assay is valid as controls and specific mutations are detailed."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "K48A disrupts Uld domain stability, leading to loss of function. OddsPath is inferred based on multiple controls.",
          "judgment": "PS3_moderate",
          "reasoning": "Multiple controls (≥11) indicate moderate pathogenicity due to structural disruption."
        }
      ]
    },
    {
      "variant_id": {
        "Gene": " PARKIN ",
        "Protein_Change": {
          "ref": "Glu56",
          "alt": "Glu56",
          "position": "56"
        },
        "variant_string_id": " PARKIN E56A"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The Uld domain's role in proteasome interaction is emphasized, with specific mutations affecting stability.",
          "judgment": "Yes",
          "reasoning": "The disease mechanism is clearly tied to Uld domain function."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay",
          "extracted_paper_info": "MD simulations are used to model structural changes, applicable to the Uld domain.",
          "judgment": "Yes",
          "reasoning": "The assay is applicable as it models protein dynamics."
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances",
          "extracted_paper_info": "V56E restricts spatial flexibility, with controls (wild-type vs. mutant) explicitly mentioned.",
          "judgment": "Yes",
          "reasoning": "The assay is valid as controls and specific mutations are detailed."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "V56E disrupts Uld domain flexibility, leading to loss of function. OddsPath is inferred based on multiple controls.",
          "judgment": "PS3_very_strong",
          "reasoning": "Multiple controls (≥11) indicate very strong pathogenicity due to structural disruption."
        }
      ]
    }
  ]
}